2020 Q2 Form 10-Q Financial Statement

#000105635820000070 Filed on August 11, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $37.60M $40.70M
YoY Change -7.62% -9.83%
Cost Of Revenue $8.708M $8.115M
YoY Change 7.31% -0.32%
Gross Profit $28.94M $32.60M
YoY Change -11.22% -11.89%
Gross Profit Margin 76.97% 80.09%
Selling, General & Admin $22.50M $25.20M
YoY Change -10.71% -12.8%
% of Gross Profit 77.75% 77.31%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $537.0K $517.0K
YoY Change 3.87% -3.36%
% of Gross Profit 1.86% 1.59%
Operating Expenses $27.83M $30.58M
YoY Change -8.99% -18.12%
Operating Profit $1.110M $2.019M
YoY Change -45.02% -678.51%
Interest Expense $0.00 $0.00
YoY Change -100.0%
% of Operating Profit 0.0% 0.0%
Other Income/Expense, Net $166.0K $980.0K
YoY Change -83.06% 105.88%
Pretax Income $1.289M $3.024M
YoY Change -57.37% 1063.08%
Income Tax $159.0K $1.037M
% Of Pretax Income 12.34% 34.29%
Net Earnings $1.130M $1.987M
YoY Change -43.13% -617.45%
Net Earnings / Revenue 3.01% 4.88%
Basic Earnings Per Share $0.48 $0.83
Diluted Earnings Per Share $0.47 $0.81
COMMON SHARES
Basic Shares Outstanding 2.370M shares 2.394M shares
Diluted Shares Outstanding 2.390M shares 2.452M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.70M $25.00M
YoY Change -17.2% -13.19%
Cash & Equivalents $20.71M $25.02M
Short-Term Investments
Other Short-Term Assets $12.00M $6.800M
YoY Change 76.47% -16.05%
Inventory $13.30M $13.34M
Prepaid Expenses
Receivables $300.0K $126.0K
Other Receivables $1.300M $200.0K
Total Short-Term Assets $41.33M $45.40M
YoY Change -8.96% -4.24%
LONG-TERM ASSETS
Property, Plant & Equipment $12.90M $11.00M
YoY Change 17.27% 69.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.99M $8.482M
YoY Change 41.31% 121.64%
Total Long-Term Assets $22.81M $21.87M
YoY Change 4.29% -5.87%
TOTAL ASSETS
Total Short-Term Assets $41.33M $45.40M
Total Long-Term Assets $22.81M $21.87M
Total Assets $64.14M $67.27M
YoY Change -4.65% -4.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.971M $5.961M
YoY Change 0.17% -7.06%
Accrued Expenses $8.200M $7.961M
YoY Change 3.0% 25.75%
Deferred Revenue $4.800M $5.783M
YoY Change -17.0% -20.64%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.000M $900.0K
YoY Change 11.11% -18.18%
Total Short-Term Liabilities $31.50M $33.92M
YoY Change -7.13% -1.8%
LONG-TERM LIABILITIES
Long-Term Debt $300.0K $800.0K
YoY Change -62.5% -11.11%
Other Long-Term Liabilities $7.700M $5.256M
YoY Change 46.5% 87.05%
Total Long-Term Liabilities $7.700M $5.256M
YoY Change 46.5% 87.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $31.50M $33.92M
Total Long-Term Liabilities $7.700M $5.256M
Total Liabilities $39.50M $40.02M
YoY Change -1.31% 1.64%
SHAREHOLDERS EQUITY
Retained Earnings $2.628M -$710.0K
YoY Change -470.14% -124.81%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $14.42M $9.778M
YoY Change 47.51% 0.82%
Treasury Stock Shares 641.6K shares 350.0K shares
Shareholders Equity $24.64M $27.25M
YoY Change
Total Liabilities & Shareholders Equity $64.14M $67.27M
YoY Change -4.65% -4.77%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $1.130M $1.987M
YoY Change -43.13% -617.45%
Depreciation, Depletion And Amortization $537.0K $517.0K
YoY Change 3.87% -3.36%
Cash From Operating Activities $370.0K $3.900M
YoY Change -90.51% 441.67%
INVESTING ACTIVITIES
Capital Expenditures -$250.0K -$250.0K
YoY Change 0.0% -68.35%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$250.0K -$250.0K
YoY Change 0.0% -65.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $5.000M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.200M -780.0K
YoY Change 566.67% -89.68%
NET CHANGE
Cash From Operating Activities 370.0K 3.900M
Cash From Investing Activities -250.0K -250.0K
Cash From Financing Activities -5.200M -780.0K
Net Change In Cash -5.080M 2.870M
YoY Change -277.0% -137.91%
FREE CASH FLOW
Cash From Operating Activities $370.0K $3.900M
Capital Expenditures -$250.0K -$250.0K
Free Cash Flow $620.0K $4.150M
YoY Change -85.06% 174.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
MANNATECH INC
dei Entity Central Index Key
EntityCentralIndexKey
0001056358
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2101240 shares
dei Entity Shell Company
EntityShellCompany
false
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
654000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
708000 USD
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
99000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
99000000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2742857 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2742857 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2101240 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2381131 shares
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
641617 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
361726 shares
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
700000 USD
CY2019Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
200000 USD
CY2019Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
200000 USD
CY2019Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
200000 USD
CY2019Q4 mtex Accrued Lease Restoration Costs
AccruedLeaseRestorationCosts
300000 USD
CY2019Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
300000 USD
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.125
CY2020Q2 us-gaap Dividends
Dividends
300000 USD
CY2020Q3 us-gaap Other Borrowings
OtherBorrowings
2243687 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20712000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24762000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
943000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
943000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
251000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
955000 USD
CY2020Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1333000 USD
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
220000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
13319000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
10152000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3122000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2239000 USD
CY2020Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
1650000 USD
CY2019Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
1758000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
41330000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
41029000 USD
CY2020Q2 mtex Property Plant And Equipment Net Excluding Construction In Progress
PropertyPlantAndEquipmentNetExcludingConstructionInProgress
4456000 USD
CY2019Q4 mtex Property Plant And Equipment Net Excluding Construction In Progress
PropertyPlantAndEquipmentNetExcludingConstructionInProgress
5261000 USD
CY2020Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
1131000 USD
CY2019Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
865000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4242000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5295000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11986000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9592000 USD
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
991000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
881000 USD
CY2020Q2 us-gaap Assets
Assets
64136000 USD
CY2019Q4 us-gaap Assets
Assets
62923000 USD
CY2020Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
84000 USD
CY2019Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
87000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5971000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3526000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8162000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8209000 USD
CY2020Q2 mtex Commissions And Incentives Payable
CommissionsAndIncentivesPayable
9981000 USD
CY2019Q4 mtex Commissions And Incentives Payable
CommissionsAndIncentivesPayable
9728000 USD
CY2020Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
1609000 USD
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2187000 USD
CY2020Q2 us-gaap Notes Payable Current
NotesPayableCurrent
889000 USD
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
739000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4801000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4416000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
31497000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
28892000 USD
CY2020Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
178000 USD
CY2019Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
176000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3000 USD
CY2020Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
92000 USD
CY2019Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
363000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7727000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6214000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
39497000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
35648000 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
33764000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
34143000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2628000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-690000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2671000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3757000 USD
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
14424000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
9935000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
24639000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
27275000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
64136000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
62923000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37647000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40711000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74252000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74252000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78684000 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
8708000 USD
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
8115000 USD
us-gaap Cost Of Revenue
CostOfRevenue
15716000 USD
us-gaap Cost Of Revenue
CostOfRevenue
15716000 USD
us-gaap Cost Of Revenue
CostOfRevenue
15542000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
28939000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
32596000 USD
us-gaap Gross Profit
GrossProfit
58536000 USD
us-gaap Gross Profit
GrossProfit
58536000 USD
us-gaap Gross Profit
GrossProfit
63142000 USD
CY2020Q2 mtex Commissions And Incentives Expense
CommissionsAndIncentivesExpense
15330000 USD
CY2019Q2 mtex Commissions And Incentives Expense
CommissionsAndIncentivesExpense
16295000 USD
mtex Commissions And Incentives Expense
CommissionsAndIncentivesExpense
30219000 USD
mtex Commissions And Incentives Expense
CommissionsAndIncentivesExpense
30219000 USD
mtex Commissions And Incentives Expense
CommissionsAndIncentivesExpense
31494000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7165000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8381000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14020000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14020000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15957000 USD
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
537000 USD
CY2019Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
517000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1057000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1045000 USD
CY2020Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4797000 USD
CY2019Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5384000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
10118000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
10118000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
11507000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
27829000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
30577000 USD
us-gaap Operating Expenses
OperatingExpenses
55414000 USD
us-gaap Operating Expenses
OperatingExpenses
55414000 USD
us-gaap Operating Expenses
OperatingExpenses
60003000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1110000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2019000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3122000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3122000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3139000 USD
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
13000 USD
CY2019Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
25000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
63000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
63000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-70000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
166000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
980000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-42000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-42000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
984000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1289000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3024000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3143000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3143000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4053000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
159000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1037000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-775000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-775000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1378000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1130000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
1987000 USD
us-gaap Net Income Loss
NetIncomeLoss
3918000 USD
us-gaap Net Income Loss
NetIncomeLoss
3918000 USD
us-gaap Net Income Loss
NetIncomeLoss
2675000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.12
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.09
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2370000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2394000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2380000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2395000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2388000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2452000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2402000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2457000 shares
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1130000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
1987000 USD
us-gaap Net Income Loss
NetIncomeLoss
3918000 USD
us-gaap Net Income Loss
NetIncomeLoss
2675000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
548000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-189000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1086000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-630000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1678000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1798000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2832000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2045000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
27275000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
2787000 USD
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
300000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
83000 USD
CY2020Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
210000 USD
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
86000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1634000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
28335000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1130000 USD
CY2020Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
299000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
5109000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
548000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
24639000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
25324000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
688000 USD
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
303000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
107000 USD
CY2019Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
280000 USD
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-441000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
25646000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
1987000 USD
CY2019Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
300000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
160000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-1000 USD
CY2019Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
58000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-189000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-739000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
91000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
27245000 USD
us-gaap Net Income Loss
NetIncomeLoss
3918000 USD
us-gaap Net Income Loss
NetIncomeLoss
2675000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1057000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1045000 USD
mtex Operating Right Of Use Lease Liabilities Net
OperatingRightOfUseLeaseLiabilitiesNet
1136000 USD
mtex Operating Right Of Use Lease Liabilities Net
OperatingRightOfUseLeaseLiabilitiesNet
882000 USD
us-gaap Inventory Write Down
InventoryWriteDown
194000 USD
us-gaap Inventory Write Down
InventoryWriteDown
436000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-35000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
71000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
8000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-62000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
327000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
547000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-110000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
453000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
1113000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-163000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3361000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
952000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1008000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1299000 USD
mtex Increase Decrease In Capitalized Contract Costs
IncreaseDecreaseInCapitalizedContractCosts
-108000 USD
mtex Increase Decrease In Capitalized Contract Costs
IncreaseDecreaseInCapitalizedContractCosts
223000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
897000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
399000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2445000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-763000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-972000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-331000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-578000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-74000 USD
mtex Increase Decrease In Commissions And Incentives Payable
IncreaseDecreaseInCommissionsAndIncentivesPayable
253000 USD
mtex Increase Decrease In Commissions And Incentives Payable
IncreaseDecreaseInCommissionsAndIncentivesPayable
-1498000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
385000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
509000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2480000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3811000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
478000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
684000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-478000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-684000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5195000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
67000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
600000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
603000 USD
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
2244000 USD
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
-2244000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
242000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
668000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6037000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1338000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1068000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-603000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5103000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1186000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31000000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30584000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25897000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31770000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
821000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1049000 USD
us-gaap Interest Paid Net
InterestPaidNet
40000 USD
us-gaap Interest Paid Net
InterestPaidNet
69000 USD
mtex Non Cash Operating Lease Right Of Use Assets And Lease Liabilities
NonCashOperatingLeaseRightOfUseAssetsAndLeaseLiabilities
0 USD
mtex Non Cash Operating Lease Right Of Use Assets And Lease Liabilities
NonCashOperatingLeaseRightOfUseAssetsAndLeaseLiabilities
4638000 USD
mtex Non Cash Finance Lease Right Of Use Assets And Lease Liabilities
NonCashFinanceLeaseRightOfUseAssetsAndLeaseLiabilities
0 USD
mtex Non Cash Finance Lease Right Of Use Assets And Lease Liabilities
NonCashFinanceLeaseRightOfUseAssetsAndLeaseLiabilities
103000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2670000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
854000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
47000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
241000 USD
mtex Number Of Regions In Which Company Sells Products
NumberOfRegionsInWhichCompanySellsProducts
3 region
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of the Company’s consolidated financial statements in accordance with GAAP requires the use of estimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The Company continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have not varied materially from the Company’s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. However, actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="text-indent:36pt;text-align:justify;"><span><br/></span></div><div style="text-indent:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The use of estimates is pervasive throughout the consolidated financial statements, but the accounting policies and estimates considered the most significant are described in this note to the consolidated financial statements, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Organization and Summary of Significant Accounting Policies</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</span></div>
CY2020Q2 us-gaap Credit Card Receivables
CreditCardReceivables
2400000 USD
CY2019Q4 us-gaap Credit Card Receivables
CreditCardReceivables
700000 USD
CY2020Q2 us-gaap Due From Banks
DueFromBanks
17000000.0 USD
CY2019Q4 us-gaap Due From Banks
DueFromBanks
18200000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
5200000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
6200000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24762000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21845000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
943000 USD
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1514000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5295000 USD
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7225000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31000000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30584000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20712000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24762000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
943000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
943000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4242000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5295000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25897000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31000000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
300000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1000000.0 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
700000 USD
CY2019Q4 mtex Noninventoryaccrualcurrent
Noninventoryaccrualcurrent
2200000 USD
CY2020Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
800000 USD
CY2020Q2 us-gaap Other Assets Current
OtherAssetsCurrent
12000000.0 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9600000 USD
CY2020Q2 us-gaap Security Deposit
SecurityDeposit
2000000.0 USD
CY2019Q4 us-gaap Security Deposit
SecurityDeposit
2200000 USD
CY2020Q2 us-gaap Deposit Assets
DepositAssets
2500000 USD
CY2019Q4 us-gaap Deposit Assets
DepositAssets
1600000 USD
CY2019Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
200000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8200000 USD
CY2020Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2300000 USD
CY2020Q2 mtex Noninventoryaccrualcurrent
Noninventoryaccrualcurrent
2400000 USD
CY2019Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
900000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
700000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1200000 USD
CY2020Q2 us-gaap Notes Payable
NotesPayable
1000000.0 USD
CY2019Q4 us-gaap Notes Payable
NotesPayable
1100000 USD
CY2020Q2 us-gaap Notes Payable Current
NotesPayableCurrent
900000 USD
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
700000 USD
CY2020Q2 us-gaap Other Borrowings
OtherBorrowings
2200000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7700000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6200000 USD
CY2020Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
200000 USD
CY2020Q2 mtex Accrued Lease Restoration Costs
AccruedLeaseRestorationCosts
300000 USD
CY2020Q2 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
300000 USD
CY2019Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
1800000 USD
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
900000 USD
CY2020Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
1700000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4400000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
2400000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4800000 USD
CY2020Q2 mtex Customer Loyalty Program Contract Liability Current
CustomerLoyaltyProgramContractLiabilityCurrent
3100000 USD
CY2019Q4 mtex Customer Loyalty Program Contract Liability Current
CustomerLoyaltyProgramContractLiabilityCurrent
3100000 USD
CY2018Q4 mtex Customer Loyalty Program Contract Liability Current
CustomerLoyaltyProgramContractLiabilityCurrent
4231000 USD
CY2019 mtex Customer Contract Loyalty Points Forfeited
CustomerContractLoyaltyPointsForfeited
4348000 USD
CY2019 mtex Customer Contracts Loyalty Points Used
CustomerContractsLoyaltyPointsUsed
9127000 USD
CY2019 mtex Customer Contract Loyalty Points Vested
CustomerContractLoyaltyPointsVested
11320000 USD
CY2019 mtex Customer Loyalty Points Unvested
CustomerLoyaltyPointsUnvested
1051000 USD
CY2019Q4 mtex Customer Loyalty Program Contract Liability Current
CustomerLoyaltyProgramContractLiabilityCurrent
3127000 USD
CY2019Q4 mtex Customer Loyalty Program Contract Liability Current
CustomerLoyaltyProgramContractLiabilityCurrent
3127000 USD
mtex Customer Contract Loyalty Points Forfeited
CustomerContractLoyaltyPointsForfeited
1659000 USD
mtex Customer Contracts Loyalty Points Used
CustomerContractsLoyaltyPointsUsed
4649000 USD
mtex Customer Contract Loyalty Points Vested
CustomerContractLoyaltyPointsVested
5124000 USD
mtex Customer Loyalty Points Unvested
CustomerLoyaltyPointsUnvested
1121000 USD
CY2020Q2 mtex Customer Loyalty Program Contract Liability Current
CustomerLoyaltyProgramContractLiabilityCurrent
3064000 USD
mtex Percentage Of Sale Returns
PercentageOfSaleReturns
0.015
CY2020Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
2755000 USD
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2685000 USD
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11060000 USD
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8341000 USD
CY2020Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
496000 USD
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
874000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
13319000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
10152000 USD
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.123
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.247
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.343
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.340
mtex U.S.Net Operating Loss Carryback
U.S.NetOperatingLossCarryback
1200000 USD
CY2020Q2 mtex Average Share Price
AverageSharePrice
13.00
mtex Average Share Price
AverageSharePrice
13.61
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2370000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2380000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
20000.00 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2390000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2400000 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000 shares
CY2019Q2 mtex Average Share Price
AverageSharePrice
17.29
mtex Average Share Price
AverageSharePrice
18.12
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2400000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
60000.00 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2460000 shares
CY2020Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
5000000.0 USD
CY2020Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
294117 shares
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
370000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
144393 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
15000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
4.00
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
6.88
CY2020Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
5000000.0 USD
CY2020Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
294117 shares
CY2020Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
17.00
CY2020Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
5000000.0 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
306123 shares
CY2020Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
294117 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4039 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2101240 shares
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.125
CY2020Q1 us-gaap Dividends
Dividends
300000 USD
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.125
CY2020Q2 us-gaap Dividends
Dividends
300000 USD
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
LITIGATION<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">        </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">Administrative Proceeding</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">        Mannatech Korea, Ltd. v. Busan Custom Office</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">, Busan District Court, Korea</span></div><div style="text-indent:36pt;text-align:justify;"><span><br/></span></div><div style="text-indent:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On or before April 12, 2015, Mannatech Korea, Ltd. filed a suit against the Busan Custom Office (“BCO”) to challenge BCO’s method of calculation regarding its assessment notice issued on July 11, 2013. The assessment notice included an audit of the Company’s imported goods covering fiscal years 2008 through 2012 and required the Company to pay $1.0 million for this assessment, all of which was paid in January 2014. Both parties submitted a response to the Court’s inquiry on January 15, 2016. The final hearing for the case was held on May 26, 2016 where each party presented their respective arguments. The Court set the decision hearing on October 27, 2016, and the Court decided the case in the Company’s favor. However, on November 18, 2016, BCO filed an appeal to the Busan High Court. The first hearing occurred on March 31, 2017, and the second hearing occurred on April 21, 2017. The final hearing was held on June 2, 2017. The Court issued its decision on June 30, 2017 in favor of the BCO. The Company appealed this decision on August 24, 2017. Since the appeal of the </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">decision of the Busan High Court to the Supreme Court, there have been no further developments and the Company is still awaiting the decision of the Supreme Court. This matter remains open.</span></div><div style="text-indent:36pt;text-align:justify;"><span><br/></span></div><div style="text-indent:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">Insured Litigation - Product Liability</span></div><div style="text-indent:36pt;"><span><br/></span></div><div style="text-align:justify;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">        Meeja Kim, et al., v. Mannatech Korea and Eunbee Cho, Seoul Southern District Court 2020-Gadan-216374</span></div><div style="text-indent:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On March 4, 2020, a complaint was filed against Mannatech Korea. Mannatech Korea was served on March 10, 2020. The plaintiffs are the surviving spouse and three children (the “Plaintiffs”) of Kong Seokhwan, a cancer patient who died in October 2017. The Plaintiffs allege that co-defendant and former independent associate, Eunbee Cho, instructed the deceased to take the Company’s products as treatment for cancer. Eunbee Cho was found guilty of fraud and began serving a sentence of one year and six months in November 2019. The Plaintiffs are seeking damages in the amount of 110 million KRW (USD $90,000.00) plus interest of 12% per year. Mannatech Korea has engaged local counsel to defend this matter. Court hearings have been delayed due to COVID-19. It is not possible at this time to predict whether the Company will incur any liability, or to estimate the ranges of damages, if any, which may be incurred in connection with this matter. However, Mannatech Korea believes it has a valid defense and will vigorously defend this claim. This matter remains open.</span></div><div style="text-indent:36pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">        Ruiguo Ma v. MTEX Hong Kong Limited and Beili Guan, Case No. 2019-Jin-0116-Civil-2339, Binhai New District Court, Tianjin, China</span></div><div style="text-indent:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On or before September 2, 2019, the Company received service of process of the above-captioned matter. Ruiguo Ma, (the "Plaintiff") is alleging that his child suffered tooth decay after consuming the Company's MannaBears product and underwent several surgeries. The Plaintiff is seeking damages of approximately $50,000 USD. The Company has engaged local counsel to defend this case. The Company has provided notice to its insurance carrier. At this time the potential damages do not meet the deductible; therefore, the case has not been tendered to the carrier. The first hearing occurred on September 11, 2019, and the second hearing occurred on October 30, 2019, where each party presented their respective arguments. Court hearings and judgments are postponed due to COVID-19. The Company anticipates a judgment in the third quarter of 2020. </span></div><div style="text-indent:36pt;text-align:justify;"><span><br/></span></div><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">Litigation in</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">General</span></div><div style="text-indent:36pt;text-align:justify;"><span><br/></span></div><div style="text-indent:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has incurred several claims in the normal course of business. The Company believes such claims can be resolved without any material adverse effect on our consolidated financial position, results of operations, or cash flows.</span></div><div style="text-indent:36pt;text-align:justify;"><span><br/></span></div><div style="text-indent:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company maintains certain liability insurance; however, certain costs of defending lawsuits are not covered by or only partially covered by its insurance policies, including claims that are below insurance deductibles. Additionally, insurance carriers could refuse to cover certain claims, in whole or in part. The Company accrues costs to defend itself from litigation as they are incurred.</span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">        The outcome of litigation is uncertain, and despite management’s views of the merits of any litigation, or the reasonableness of the Company’s estimates and reserves, the Company’s financial statements could nonetheless be materially affected by an adverse judgment. The Company believes it has adequately reserved for the contingencies arising from current legal matters where an outcome was deemed to be probable, and the loss amount could be reasonably estimated.</span></div>
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y8M23D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.041
CY2020Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M8D
CY2020Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.056
CY2020Q2 mtex Financeand Operating Lease Assets
FinanceandOperatingLeaseAssets
7615000 USD
CY2019Q2 mtex Financeand Operating Lease Assets
FinanceandOperatingLeaseAssets
4800000 USD
CY2020Q2 mtex Financeand Operating Lease Liabilities
FinanceandOperatingLeaseLiabilities
8961000 USD
CY2019Q2 mtex Financeand Operating Lease Liabilities
FinanceandOperatingLeaseLiabilities
6236000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1227000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
49000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2151000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
94000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1705000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
74000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1159000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
45000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1242000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
21000 USD
CY2020Q2 mtex Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
865000 USD
CY2020Q2 mtex Finance Lease Liability Payments Due Year Six
FinanceLeaseLiabilityPaymentsDueYearSix
1000 USD
CY2020Q2 mtex Lessee Operating Lease Liability Payments Due After Year Six
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix
1528000 USD
CY2020Q2 mtex Finance Lease Liability Payments Due After Year Six
FinanceLeaseLiabilityPaymentsDueAfterYearSix
0 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9877000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
284000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1178000 USD
CY2020Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
22000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
8699000 USD
CY2020Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
262000 USD
mtex Number Of Countries In Which Entity Network Marketing And Distribution Channels Operates
NumberOfCountriesInWhichEntityNetworkMarketingAndDistributionChannelsOperates
24 country
CY2020Q2 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
11 country
mtex Number Of Countries In Which Entity Sells Products
NumberOfCountriesInWhichEntitySellsProducts
25 country
mtex Number Of Regions In Which Company Sells Products
NumberOfRegionsInWhichCompanySellsProducts
3 region
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37600000 USD
CY2020Q2 mtex Sales Revenue Goods Percentage
SalesRevenueGoodsPercentage
1.000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40700000 USD
CY2019Q2 mtex Sales Revenue Goods Percentage
SalesRevenueGoodsPercentage
1.000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74300000 USD
mtex Sales Revenue Goods Percentage
SalesRevenueGoodsPercentage
1.000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78700000 USD
mtex Sales Revenue Goods Percentage
SalesRevenueGoodsPercentage
1.000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37600000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40700000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74300000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78700000 USD
CY2020Q2 us-gaap Noncurrent Assets
NoncurrentAssets
5600000 USD
CY2019Q4 us-gaap Noncurrent Assets
NoncurrentAssets
6100000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
13300000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
10200000 USD

Files In Submission

Name View Source Status
0001056358-20-000070-index-headers.html Edgar Link pending
0001056358-20-000070-index.html Edgar Link pending
0001056358-20-000070.txt Edgar Link pending
0001056358-20-000070-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mtex-20200630.htm Edgar Link pending
mtex-20200630.xsd Edgar Link pending
mtex-20200630_cal.xml Edgar Link unprocessable
mtex-20200630_def.xml Edgar Link unprocessable
mtex-20200630_htm.xml Edgar Link completed
mtex-20200630_lab.xml Edgar Link unprocessable
mtex-20200630_pre.xml Edgar Link unprocessable
mtexq2202010-qexh311.htm Edgar Link pending
mtexq2202010-qexh312.htm Edgar Link pending
mtexq2202010-qexh321.htm Edgar Link pending
mtexq2202010-qexh322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending